Gene based pharmacophores for drug design

Virendra B. Mahesh, Lewis W. Roach, William E. Cannady, Thomas F. Ogle, Darrell W Brann, Edwin D. Bransome, Lawrence B. Hendry

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

A new patented technology for drug discovery based upon gene structure utilizes the discovery of stereochemical relationships between small biologically active ligands and specific unwound DNA sequences to create pharmacophores for drug design. The estrogen gene pharmacophore was used to design a new estrogen PDC-7 which as predicted was more estrogenic (2-3 times) in classical in vivo assays than the natural hormone estradiol. Poor fit of PDC-7 into the estrogen receptor protein pharmacophore explained poor binding (15-18%) to the estrogen receptor relative to estradiol. These findings support the hypothesis that receptor assisted insertion of ligand into DNA is a mode of action of certain gene regulatory pharmaceuticals and provide powerful tool for new drug design.

Original languageEnglish (US)
Pages (from-to)440-455
Number of pages16
JournalMedicinal Chemistry Research
Volume10
Issue number7-8
StatePublished - Dec 1 2001

Fingerprint

Drug Design
Estradiol
Estrogens
Genes
Ligands
Drug Discovery
Regulator Genes
Estrogen Receptors
Pharmaceutical Preparations
DNA sequences
Hormones
Technology
Assays
DNA
estrophilin

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Organic Chemistry

Cite this

Mahesh, V. B., Roach, L. W., Cannady, W. E., Ogle, T. F., Brann, D. W., Bransome, E. D., & Hendry, L. B. (2001). Gene based pharmacophores for drug design. Medicinal Chemistry Research, 10(7-8), 440-455.

Gene based pharmacophores for drug design. / Mahesh, Virendra B.; Roach, Lewis W.; Cannady, William E.; Ogle, Thomas F.; Brann, Darrell W; Bransome, Edwin D.; Hendry, Lawrence B.

In: Medicinal Chemistry Research, Vol. 10, No. 7-8, 01.12.2001, p. 440-455.

Research output: Contribution to journalArticle

Mahesh, VB, Roach, LW, Cannady, WE, Ogle, TF, Brann, DW, Bransome, ED & Hendry, LB 2001, 'Gene based pharmacophores for drug design', Medicinal Chemistry Research, vol. 10, no. 7-8, pp. 440-455.
Mahesh VB, Roach LW, Cannady WE, Ogle TF, Brann DW, Bransome ED et al. Gene based pharmacophores for drug design. Medicinal Chemistry Research. 2001 Dec 1;10(7-8):440-455.
Mahesh, Virendra B. ; Roach, Lewis W. ; Cannady, William E. ; Ogle, Thomas F. ; Brann, Darrell W ; Bransome, Edwin D. ; Hendry, Lawrence B. / Gene based pharmacophores for drug design. In: Medicinal Chemistry Research. 2001 ; Vol. 10, No. 7-8. pp. 440-455.
@article{3fca61d810d14c278741ffe01abc45eb,
title = "Gene based pharmacophores for drug design",
abstract = "A new patented technology for drug discovery based upon gene structure utilizes the discovery of stereochemical relationships between small biologically active ligands and specific unwound DNA sequences to create pharmacophores for drug design. The estrogen gene pharmacophore was used to design a new estrogen PDC-7 which as predicted was more estrogenic (2-3 times) in classical in vivo assays than the natural hormone estradiol. Poor fit of PDC-7 into the estrogen receptor protein pharmacophore explained poor binding (15-18{\%}) to the estrogen receptor relative to estradiol. These findings support the hypothesis that receptor assisted insertion of ligand into DNA is a mode of action of certain gene regulatory pharmaceuticals and provide powerful tool for new drug design.",
author = "Mahesh, {Virendra B.} and Roach, {Lewis W.} and Cannady, {William E.} and Ogle, {Thomas F.} and Brann, {Darrell W} and Bransome, {Edwin D.} and Hendry, {Lawrence B.}",
year = "2001",
month = "12",
day = "1",
language = "English (US)",
volume = "10",
pages = "440--455",
journal = "Medicinal Chemistry Research",
issn = "1054-2523",
publisher = "Birkhause Boston",
number = "7-8",

}

TY - JOUR

T1 - Gene based pharmacophores for drug design

AU - Mahesh, Virendra B.

AU - Roach, Lewis W.

AU - Cannady, William E.

AU - Ogle, Thomas F.

AU - Brann, Darrell W

AU - Bransome, Edwin D.

AU - Hendry, Lawrence B.

PY - 2001/12/1

Y1 - 2001/12/1

N2 - A new patented technology for drug discovery based upon gene structure utilizes the discovery of stereochemical relationships between small biologically active ligands and specific unwound DNA sequences to create pharmacophores for drug design. The estrogen gene pharmacophore was used to design a new estrogen PDC-7 which as predicted was more estrogenic (2-3 times) in classical in vivo assays than the natural hormone estradiol. Poor fit of PDC-7 into the estrogen receptor protein pharmacophore explained poor binding (15-18%) to the estrogen receptor relative to estradiol. These findings support the hypothesis that receptor assisted insertion of ligand into DNA is a mode of action of certain gene regulatory pharmaceuticals and provide powerful tool for new drug design.

AB - A new patented technology for drug discovery based upon gene structure utilizes the discovery of stereochemical relationships between small biologically active ligands and specific unwound DNA sequences to create pharmacophores for drug design. The estrogen gene pharmacophore was used to design a new estrogen PDC-7 which as predicted was more estrogenic (2-3 times) in classical in vivo assays than the natural hormone estradiol. Poor fit of PDC-7 into the estrogen receptor protein pharmacophore explained poor binding (15-18%) to the estrogen receptor relative to estradiol. These findings support the hypothesis that receptor assisted insertion of ligand into DNA is a mode of action of certain gene regulatory pharmaceuticals and provide powerful tool for new drug design.

UR - http://www.scopus.com/inward/record.url?scp=0035689839&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035689839&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0035689839

VL - 10

SP - 440

EP - 455

JO - Medicinal Chemistry Research

JF - Medicinal Chemistry Research

SN - 1054-2523

IS - 7-8

ER -